Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Case-matched Comparison of Cardiovascular Outcome in Loeys-Dietz Syndrome versus Marfan Syndrome.
Mühlstädt K, De Backer J, von Kodolitsch Y, Kutsche K, Muiño Mosquera L, Brickwedel J, Girdauskas E, Mir TS, Mahlmann A, Tsilimparis N, Staebler A, Schoof L, Seidel H, Berger J, Bernhardt AM, Blankenberg S, Kölbel T, Detter C, Szöcs K, Kaemmerer H. Mühlstädt K, et al. Among authors: szocs k. J Clin Med. 2019 Nov 29;8(12):2079. doi: 10.3390/jcm8122079. J Clin Med. 2019. PMID: 31795342 Free PMC article.
Marfan Syndrome Versus Bicuspid Aortic Valve Disease: Comparative Analysis of Obstetric Outcome and Pregnancy-Associated Immediate and Long-Term Aortic Complications.
Toprak B, Szöcs K, Zengin-Sahm E, Sinning C, Hot A, Bannas P, Hecher K, Hüneke B, Mir TS, Rybczynski M, Girdauskas E, Blankenberg S, von Kodolitsch Y. Toprak B, et al. Among authors: szocs k. J Clin Med. 2020 Apr 15;9(4):1124. doi: 10.3390/jcm9041124. J Clin Med. 2020. PMID: 32326432 Free PMC article.
Features of Marfan syndrome not listed in the Ghent nosology - the dark side of the disease.
von Kodolitsch Y, Demolder A, Girdauskas E, Kaemmerer H, Kornhuber K, Muino Mosquera L, Morris S, Neptune E, Pyeritz R, Rand-Hendriksen S, Rahman A, Riise N, Robert L, Staufenbiel I, Szöcs K, Vanem TT, Linke SJ, Vogler M, Yetman A, De Backer J. von Kodolitsch Y, et al. Among authors: szocs k. Expert Rev Cardiovasc Ther. 2019 Dec;17(12):883-915. doi: 10.1080/14779072.2019.1704625. Expert Rev Cardiovasc Ther. 2019. PMID: 31829751 Review.
Arrhythmia and impaired myocardial function in heritable thoracic aortic disease: An international retrospective cohort study.
Demolder A, Bianco L, Caruana M, Cervi E, Evangelista A, Jondeau G, Buttigieg LL, López-Sainz Á, Delmás EM, Pini A, Sabaté-Rotés A, Szöcs K, Tchitchinadze M, Teixidó-Tura G, von Kodolitsch Y, Muiño-Mosquera L, De Backer J. Demolder A, et al. Among authors: szocs k. Eur J Med Genet. 2022 Jun;65(6):104503. doi: 10.1016/j.ejmg.2022.104503. Epub 2022 Apr 12. Eur J Med Genet. 2022. PMID: 35427808 Free article.
Myeloperoxidase upregulates endothelin receptor type B expression.
Lau D, Szöcs K, Klinke A, Rudolph T, Rudolph V, Streichert T, Blankenberg S, Baldus S. Lau D, et al. Among authors: szocs k. J Mol Cell Cardiol. 2014 Apr;69:76-82. doi: 10.1016/j.yjmcc.2013.12.007. Epub 2014 Jan 10. J Mol Cell Cardiol. 2014. PMID: 24417960
Myeloperoxidase attracts neutrophils by physical forces.
Klinke A, Nussbaum C, Kubala L, Friedrichs K, Rudolph TK, Rudolph V, Paust HJ, Schröder C, Benten D, Lau D, Szocs K, Furtmüller PG, Heeringa P, Sydow K, Duchstein HJ, Ehmke H, Schumacher U, Meinertz T, Sperandio M, Baldus S. Klinke A, et al. Among authors: szocs k. Blood. 2011 Jan 27;117(4):1350-8. doi: 10.1182/blood-2010-05-284513. Epub 2010 Oct 27. Blood. 2011. PMID: 20980678 Free article.
Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
Baldus S, Rudolph V, Roiss M, Ito WD, Rudolph TK, Eiserich JP, Sydow K, Lau D, Szöcs K, Klinke A, Kubala L, Berglund L, Schrepfer S, Deuse T, Haddad M, Risius T, Klemm H, Reichenspurner HC, Meinertz T, Heitzer T. Baldus S, et al. Among authors: szocs k. Circulation. 2006 Apr 18;113(15):1871-8. doi: 10.1161/CIRCULATIONAHA.105.590083. Epub 2006 Apr 10. Circulation. 2006. PMID: 16606792
Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase.
Rudolph V, Rudolph TK, Schopfer FJ, Bonacci G, Lau D, Szöcs K, Klinke A, Meinertz T, Freeman BA, Baldus S. Rudolph V, et al. Among authors: szocs k. J Pharmacol Exp Ther. 2008 Nov;327(2):324-31. doi: 10.1124/jpet.108.142414. Epub 2008 Aug 13. J Pharmacol Exp Ther. 2008. PMID: 18701766 Free PMC article. Clinical Trial.
35 results